Also, prior reports have shown that OSA-mediated chronic intermittent hypoxia (CIH), triggered by repetitive episodes of apneas and hypopneas, exacerbates metabolic dysfunction including insulin resistance and nonalcoholic fatty liver disease [10, 21]. This evidence concerns the gene INS and obstructive sleep apnea syndrome.